中文 | English
Return
Total: 17 , 1/2
Show Home Prev Next End page: GO
MeSH:(Anti-HIV Agents/*adverse effects/therapeutic use)

1.Reasons, safety and efficacy analysis for conversion of HAART to TAF/FTC/BIC among HIV-infected patients.

Jiang XIAO ; Guiju GAO ; Yi DING ; Jialu LI ; Chengyu GAO ; Qiuhua XU ; Liang WU ; Hongyuan LIANG ; Liang NI ; Fang WANG ; Yujiao DUAN ; Di YANG ; Hongxin ZHAO

Chinese Medical Journal 2023;136(24):2931-2937

2.A Case of Lactic Acidosis Caused by Stavudine in an AIDS Patient.

Byoung Chul CHO ; Sang Hoon HAN ; Suk Hoon CHOI ; Jun Yong CHOI ; Kyung Hee CHANG ; Young Goo SONG ; June Myung KIM

The Korean Journal of Internal Medicine 2004;19(1):66-69

3.An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China.

Taisheng LI ; Fuping GUO ; Yijia LI ; Chengda ZHANG ; Yang HAN ; Wei LYE ; Yun HE ; Hongzhou LU ; Jing XIE ; Aiqiong HUANG ; Yanling LI ; Xiaoping TANG ; Hui WANG ; Tong ZHANG ; Guiju GAO ; Junkang LEI ; Xiaoying ZHANG ; Xinhua WU ; Yongtao SUN ; Jinsong BAI ; Ling LUO ; Huanling WANG

Chinese Medical Journal 2014;127(1):59-65

4.Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen.

Li-Qin SUN ; Jia-Ye LIU ; Yun HE ; Yang ZHOU ; Liu-Mei XU ; Lu-Kun ZHANG ; Fang ZHAO ; Xiao-Ning LIU ; Ying SONG ; Ting-Zhi CAO ; Yi-Mei TIAN ; Man RAO ; Hui WANG

Chinese Medical Journal 2020;133(23):2808-2815

5.Side effects and tolerability of post-exposure prophylaxis with zidovudine, lamivudine, and lopinavir/ritonavir: a comparative study with HIV/AIDS patients.

Juan CAI ; Jiang XIAO ; Qiang ZHANG

Chinese Medical Journal 2014;127(14):2632-2636

6.Overview of antiretroviral treatment in China: advancement and challenges.

Ling LUO ; Tai-Sheng LI

Chinese Medical Journal 2011;124(3):440-444

7.Analysis on efficacy action points of HIV/AIDS treatment with traditional Chinese medicine and antiretroviral drugs.

Jian WANG ; Wen ZOU ; Ying LIU

China Journal of Chinese Materia Medica 2013;38(15):2504-2506

8.The newest developments in anti-HIV-1 drugs.

Xing-quan ZHANG

Acta Pharmaceutica Sinica 2010;45(2):194-204

9.Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study.

Jing ZHOU ; Yue-Ying LIU ; Jiang-Shan LIAN ; Li-Fang PAN ; Jian-Le YANG ; Jian-Rong HUANG

Chinese Medical Journal 2017;130(8):914-919

10.Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study.

Bin SU ; Cheng YAO ; Qing-Xia ZHAO ; Wei-Ping CAI ; Min WANG ; Hong-Zhou LU ; Yuan-Yuan CHEN ; Li LIU ; Hui WANG ; Yun HE ; Yu-Huang ZHENG ; Ling-Hua LI ; Jin-Feng CHEN ; Jian-Hua YU ; Biao ZHU ; Min ZHAO ; Yong-Tao SUN ; Wen-Hui LUN ; Wei XIA ; Li-Jun SUN ; Li-Li DAI ; Tai-Yi JIANG ; Mei-Xia WANG ; Qing-Shan ZHENG ; Hai-Yan PENG ; Yao WANG ; Rong-Jian LU ; Jian-Hua HU ; Hui XING ; Yi-Ming SHAO ; Dong XIE ; Tong ZHANG ; Fu-Jie ZHANG ; Hao WU

Chinese Medical Journal 2020;133(24):2919-2927

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 17 , 1/2 Show Home Prev Next End page: GO